Cordasco Financial Network’s Capricor Therapeutics CAPR Stock Holding History

Cordasco Financial Network’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-310	Closed	-$2K	–	519
2020 Q3	$2K	Hold	310	–	–	﹤0.01%	467
2020 Q2	$1K	Hold	310	–	–	﹤0.01%	463
2020 Q1	$0	Hold	310	–	–	﹤0.01%	462
2019 Q4	$0	Hold	310	–	–	﹤0.01%	451
2019 Q3	$1K	Hold	310	–	–	﹤0.01%	452
2019 Q2	$1K	Hold	310	–	–	﹤0.01%	435
2019 Q1	$1K	Hold	310	–	–	﹤0.01%	432
2018 Q4	$1K	Hold	310	–	–	﹤0.01%	370
2018 Q3	$3K	Hold	310	–	–	﹤0.01%	311
2018 Q2	$4K	Hold	310	–	–	﹤0.01%	299
2018 Q1	$4K	Hold	310	–	–	﹤0.01%	218
2017 Q4	$5K	Hold	310	–	–	0.01%	197
2017 Q3	$9K	Buy	+310	New	+$3.71K	0.01%	181
2017 Q2	–	Sell	-310	Closed	-$10K	–	246
2017 Q1	$10K	Hold	310	–	–	0.01%	186
2016 Q4	$8K	Hold	310	–	–	0.01%	188
2016 Q3	$12K	Hold	310	–	–	0.01%	188
2016 Q2	$12K	Hold	310	–	–	0.01%	188
2016 Q1	$8K	Hold	310	–	–	0.01%	203
2015 Q4	$10K	Hold	310	–	–	0.01%	208
2015 Q3	$13K	Hold	310	–	–	0.01%	200
2015 Q2	$16K	Hold	310	–	–	0.01%	202
2015 Q1	$27K	Buy	+310	New	+$26.8K	0.02%	186

Other funds holding CAPR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cordasco Financial Network's CAPR Position: Q4 2020 in Review

Cordasco Financial Network sold out of Capricor Therapeutics (CAPR) in Q4 2020, closing a stake of 310 shares — an estimated $2K sold.

Cordasco Financial Network first reported a position in CAPR in Q1 2015 and held it in 22 quarters. The position peaked at $27K in Q1 2015. 25 funds tracked by Wall St. Rank hold CAPR as of Q4 2020.

Cordasco Financial Network reported no remaining Capricor Therapeutics position as of Q4 2020 after selling out during the quarter.
Cordasco Financial Network sold 310 Capricor Therapeutics shares in Q4 2020, an estimated $2K.
Cordasco Financial Network first reported a position in Capricor Therapeutics in Q1 2015 and held it in 22 quarters.
Cordasco Financial Network's Capricor Therapeutics position peaked at $27K in Q1 2015.
25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2020.

Based on Cordasco Financial Network's 13F filing for Q4 2020, filed 26 Jan 2021.